Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
More than 24 million Americans currently have asthma. Every day, 11 people in the United States die from asthma and the disease accounts for one-quarter of all emergency room visits each year. For many people with asthma, their home may be part of the problem.
Any house or apartment can contain a variety of asthma “triggers,” which can include allergens and irritants – such as dust mites, mold, pet dander and strong fumes or odors – that can negatively affect someone with asthma.
To view Multimedia News Release, go to http://www.multivu.com/players/English/49320-Merck-Asthma-Awareness/
TD Bank, America’s Most Convenient Bank®, will launch a series of YouTube videos to help consumers traverse all the recent changes to checking accounts. The first video offers people tips and things to consider when opening or updating their checking accounts.
http://www.digitalcameras.productzreview.com/
This website is a community of real people, just like you, that are poised in sharing their products and services experiences both online and offline. Our community review products or services with passion and unfettered. We are determined to help you discover what
